NME4 and metabolic dysfunction-associated steatotic liver disease: Taken together, we found NME4 binds to key enzymes catalyzing CoA metabolism, increases malonyl-CoA and acetyl-CoA levels, and subsequently promotes de novo lipogenesis and TG generation, ultimately leading to lipid accumulation and accelerating NAFLD progression (Fig. 7G).